ArticleJournal of experimental & clinical cancer research : CR2023

Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer.

Jiahui Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.